Metabolic syndrome and clinical outcomes in patients infected with <scp>COVID</scp>‐19: Does age, sex, and race of the patient with metabolic syndrome matter?

Abstract

MetS is a better prognostic indicator for severe disease outcomes in patients with COVID-19 than its individual components. Patients with MetS had significantly higher mortality, increased ICU admissions, and need for mechanical ventilation.